The transaction is expected to close in the second quarter of Nichi-Iko’s fiscal year in March 2017. The acquisition also raises the company’s profile as a key player in the domestic and international generics market, particularly in the U.S.
Officials at Nichi-Iko said they do not anticipate any changes to Sagent’s current operations and management team.
More issues about transactions and valuations:
Ministry Door County Medical Center, Hospital Sisters Health System pursue formal partnership
NYU Langone, Winthrop-University Hospital to begin merger talks
Henderson Hospital hiring for hundreds of open positions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
